Post by
Eoganacht on Jun 23, 2023 2:08pm
Timeline
We've treated 60 patients and it looks like we're only going to treat 40 more. If we continue treating 3 patients per month we will be finished the treatment phase by the end of July 2024. The 100th patient should receive their 450 day assessment by the end of October 2025. The data will be compiled and application to the FDA for approval to commercialize made in late 2025 or early 2026.
IMHO Roger was bang on with the timeline this time.
"In order to line this up and get all the clinical data in place and get this into a position for marketing approval which we hope to do in 2025, early 2026"
Comment by
skys1 on Jun 23, 2023 3:07pm
However, deals are often made before final approvals have been obtained. Especially when the treatment is in an area of substantial need like an effective NMIBC treatment with minor to no side effects, unlike the current treatments. .
Comment by
Eoganacht on Jun 23, 2023 3:25pm
True. There could be a whole lot of very positive developments for shareholders before final approval, including the announcement of a jv, the granting of breakthrough designation, accelerated approval, priority review and the initiation of phase 1 trials for gbm and/or nsclc.
Comment by
ScienceFirst on Jun 23, 2023 3:47pm
Roger has to go by book. We can only have though pleasant surprises like: - adding more CSS, - being granted Breakthrough Therapy designation, - receiving a BUY order from additional brokage firms, - seeing institutional firms entering our capital, - uplisting on the NASDAQ, - being selected for Accelerated Approval, - receiving an official jv offer, - etc...
Comment by
Rumpl3StiltSkin on Jun 25, 2023 8:37am
I got around to listening to the radio interview. RW does mention BTD AA Priority review at the end. So, I guess there is nothing new. We should get 'Formal' FDA approval in the '25-'26 timeframe. Yet we could still receive AA by end of this year, if BTD is applied for soon. Which it seems they are working on.
Comment by
StevenBirch on Jun 25, 2023 9:30am
Also, and my numbers may be a bit off, Roger mentioned it talking between 15 and 20 years to get to market and we are around 18 years TLT has been at this. And again commercialization is obviously the goal for the company but for the stock it should pop long before that. There are many catalysts before that point.
Comment by
riverrrow on Jun 23, 2023 3:44pm
With that kind of timeline I think Roger is going to have a tough time raising money in the foreseeable future. Remember how a bunch of posters a short while ago were predicting a pp. Where is it?
Comment by
Longholder99 on Jun 23, 2023 3:53pm
Just because it's pontificated about on an anonymous bull board......doesn't mean that it will happen.
Comment by
N0taP00p on Jun 23, 2023 4:42pm
@riverrow: you won't have to wait long. It's either going to be a raise or a JV or some other capital infusion. I'm guessing one to two weeks for an answer. Max.
Comment by
Rumpl3StiltSkin on Jun 23, 2023 5:52pm
Great question River, Maybe we get some good/great and unexpected news soon...???
Comment by
StevenBirch on Jun 23, 2023 7:31pm
Marketing approval in 2025 or early 2026 is Roger toeing the line and I think it has nothing to do with the stock price. The things that would have to happen before that can even happen would have the stock much higher than it is now. And whenever that does happen I think you are in buyout territory.
Comment by
2b7f6fab on Jun 23, 2023 3:47pm
Considering the apparent success to date, enrollment could pickup and 100 patients treated by 1st quarter 2024.